ArticleSleep & breathing = Schlaf & Atmung2026
High prevalence of low arousal threshold endotype in obstructive sleep apnea with multiple sclerosis.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeWe sought to estimate the prevalence of low arousal threshold (LAT) in individuals with multiple sclerosis (MS).
methodsWe conducted a retrospective non-matched study of individuals with documented MS as well as non-MS controls who were diagnosed with obstructive sleep apnea (OSA). Demographic, clinical characteristics, and polysomnographic measurements were extracted from the medical records. LAT was estimated from overnight polysomnography and defined as 2 or more of the following conditions: apnea-hypopnea index (AHI) < 30 events/hour, minimum oxygen saturation > 82.5%, or frequency of hypopnea events > 58.3%. A multivariate analysis was conducted to assess predictors of LAT.
resultsLAT was identified in 87.5% of 64 patients with MS and OSA, which was significantly higher than OSA controls (71.4%). On univariate analysis, LAT was significantly associated with MS status, sex, and BMI. With logistic regression, only sex (OR 3.2, 95% CI 1.2-9.7, p = 0.03) and BMI (OR 0.87, 95% CI 0.80-0.94, p = 0.0007) were associated with LAT, although MS status trended towards significance (OR 2.64, 95% CI 0.91-8.51, p = 0.084). Without sex in analysis, MS status was significantly associated with LAT (OR 3.34, 95% CI 1.21-10.4, p = 0.026). Stratifying by OSA severity indicated that differences in LAT were even more pronounced in severe OSA, with 55.5% MS versus 20.8% non-MS exhibiting LAT.
conclusionThe estimated prevalence of LAT endotype is high in MS-OSA patients, significantly exceeding rates in non-MS controls, but female sex and lower BMI are the dominant predictors. Because sex strongly confounds the relationship between MS and LAT, whether MS independently contributes to LAT beyond its demographic profile requires larger, sex-matched cohorts.
Indexed as
Identifiers
42667478What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.